In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

British endurance athlete Harry Amos completes a grueling 630km run across all seven emirates in under six days, raising Dh16 ...

Heather Bryan was diagnosed with a rare form of blood cancer, for which she was prescribed Cotellic, a pill that slows the ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

When it comes to health insurance, prescription drugs and other health costs, January 2025 was not a boring month.

A broad measure of Asian equities slipped, pressured by sell-offs in Hong Kong and mainland China. Futures for the S&P 500 ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the ...

Deputy Cleere has hailed this as a ‘game changer’ for diabetic patients, whilst pointing towards its introduction on the Drug ...